List of Excipients in API sumatriptan succinate and naproxen sodium
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sumatriptan succinate and naproxen sodium
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Rebel Distributors Corp | TREXIMET | sumatriptan succinate and naproxen sodium | 21695-954 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
| Rebel Distributors Corp | TREXIMET | sumatriptan succinate and naproxen sodium | 21695-954 | CARBOXYMETHYLCELLULOSE SODIUM | |
| Rebel Distributors Corp | TREXIMET | sumatriptan succinate and naproxen sodium | 21695-954 | CELLULOSE, MICROCRYSTALLINE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for sumatriptan succinate and naproxen sodium
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sumatriptan succinate and naproxen sodium drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sumatriptan succinate and naproxen sodium drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
sumatriptan succinate and naproxen sodium drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | sumatriptan succinate and naproxen sodium | 21695-954 |
| >Company | >Ingredient | >NDC |
sumatriptan succinate and naproxen sodium drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sumatriptan succinate and naproxen sodium drug variants containing CELLULOSE, MICROCRYSTALLINE
sumatriptan succinate and naproxen sodium drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
sumatriptan succinate and naproxen sodium drug variants containing CROSCARMELLOSE SODIUM
sumatriptan succinate and naproxen sodium drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE MONOHYDRATE
sumatriptan succinate and naproxen sodium drug variants containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | sumatriptan succinate and naproxen sodium | 21695-954 |
| >Company | >Ingredient | >NDC |
sumatriptan succinate and naproxen sodium drug variants not containing DEXTROSE MONOHYDRATE
Excipient focus: FD&C BLUE NO. 2
sumatriptan succinate and naproxen sodium drug variants containing FD&C BLUE NO. 2
sumatriptan succinate and naproxen sodium drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
sumatriptan succinate and naproxen sodium drug variants containing HYPROMELLOSE
sumatriptan succinate and naproxen sodium drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | sumatriptan succinate and naproxen sodium | 21695-954 |
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
sumatriptan succinate and naproxen sodium drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | sumatriptan succinate and naproxen sodium | 21695-954 |
| >Company | >Ingredient | >NDC |
sumatriptan succinate and naproxen sodium drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
sumatriptan succinate and naproxen sodium drug variants containing MAGNESIUM STEARATE
sumatriptan succinate and naproxen sodium drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
sumatriptan succinate and naproxen sodium drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | sumatriptan succinate and naproxen sodium | 21695-954 |
| >Company | >Ingredient | >NDC |
sumatriptan succinate and naproxen sodium drug variants not containing MALTODEXTRIN
Excipient focus: POVIDONE
sumatriptan succinate and naproxen sodium drug variants containing POVIDONE
sumatriptan succinate and naproxen sodium drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
sumatriptan succinate and naproxen sodium drug variants containing SODIUM BICARBONATE
sumatriptan succinate and naproxen sodium drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
sumatriptan succinate and naproxen sodium drug variants containing TALC
sumatriptan succinate and naproxen sodium drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
sumatriptan succinate and naproxen sodium drug variants containing TITANIUM DIOXIDE
sumatriptan succinate and naproxen sodium drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
sumatriptan succinate and naproxen sodium drug variants containing TRIACETIN
sumatriptan succinate and naproxen sodium drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | sumatriptan succinate and naproxen sodium | 21695-954 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
